Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 2926-2929

  Uslu, Nuray ^a   Demir, Hulya ^a   Saltik Temizel, Inci Nur ^a   Topaloğlu, Rezan ^a   Gürakan, Figen ^a   Yüce, Aysel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Childhood; Inflammatory bowel disease; Interstitial nephritis; Mesalazine; Tubulopathy

Indexed keywords

MESALAZINE; PREDNISOLONE;

ADOLESCENT; ARTICLE; CASE REPORT; COLONOSCOPY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; EMERGENCY WARD; ENTERITIS; FEMALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAINTENANCE THERAPY; PRIORITY JOURNAL; ULCERATIVE COLITIS; URINALYSIS;

EID: 34848830181     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9586-2     Document Type: Article

References (18)

1. Gisbert JP, Gomollon F, Mate J, Pajares JM (2002) Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci 47:471-488
2. Ransford RA, Langman MJ (2002) Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 51:536-539
3. World MJ, Stevens PE, Ashton MA, Rainford DJ (1996) Mesalazine-associated interstitial nephritis. Nephrol Dial Transplant 11:614-621
4. Manenti L, DeRosa A, Buzio C (1996) Mesalazine associated interstitial nephritis twice in the same patient. Nephrol Dial Transplant 12:2031
5. Agharazii M, Marcotte J, Boucher D, Noel R, Lebel M (1999) Chronic interstitial nephritis due to the 5-aminosalicylic acid. Am J Nephrol 19:373-376
6. Frandsen NE, Saugmann S, Marcussen N (2002) Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Nephron 92:200-202
7. Margets PJ, Churchill DN, Alexopoulou I (2001) Interstitial nephritis in patients with inflammatory bowel disease treated with mesalazine. J Clin Gastroenterol 32(2):176-178
8. De Broe ME, Stolear JC, Nouwen EJ, Elseviers MM (1997) 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link? Nephrol Dial Transplant 12:1839-1841
9. Arend LJ, Springate JE (2004) Interstitial nephritis from mesalazine: case report and literature review. Pediatr Nephrol 19:550-553
10. Behrens R, Ruder H (1992) Chronic inflammatory intestinal disease and nephritis. Klin Paditr 204:61-64
11. Corrigan G, Stevens PE (2000) Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment Pharmacol Ther 14:1-6
12. McRae Dell K, Kaplan BS, Meyers CM (1999) Tubulointerstitial nephritis. In: Barratt TM, Avner ED, Harman WE (eds). Pediatric nephrology. Philadelphia: Lippincott Williams and Wilkins, pp 823-834
13. Van Staa TP, Travis S, Leufkens HGM, Logan RF (2004) 5-Aminosalicylic acids and the risk of renal disease: A large British epidemiologic study. Gastroenterology 126:1733-1739
14. Calder IC, Funder CC, Green CR, Ham KN, Tange JD (1971) Comparative nephrotoxicity of aspirin and phenacetin derivatives. Br Med J 27:518-521
15. Fornaciari G, Maccari S, Borgatti PP, Rusticelli R, Amelio N, Lattuada I, Plancher AC (1997) Nephrotic syndrome from 5-ASA for ulcerative colitis? J Clin Gastroenterol 24:37-39
16. Hamling J, Raedler A, Helmchen U, Schreiber S (1997) 5-aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Digestion 58:304-307
17. Hoffmann RM, Kruis W (2004) Rare extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 10(2):140-147
18. Izzedine H, Simon J, Piette AM, Lucsko M, Baumelou A, Charitanski D, Kernaonet E, Baglin AC, Deray G, Beaufils H (2002) Primary chronic interstitial nephritis in Crohn's disease. Gastroenterology 123:1436-1440